Drug Trial Radar · NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
630
Planned (sponsor's estimate)
Start
Apr 24, 2025
Primary completion
Sep 7, 2029
Study completion Apr 30, 2032
Sponsor
- Lead sponsor
- Mirati Therapeutics Inc.Bristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Mar 13, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
AdagrasibDrug
Specified dose on specified days
PembrolizumabDrug
Specified dose on specified days
CarboplatinDrug
Specified dose on specified days
PemetrexedDrug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
CisplatinDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS) as Assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded Independent Central Review (BICR)Time frame: Up to 7 years
- Overall Survival (OS)Time frame: Up to 7 years
Locations
317 sites in 35 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Highlands Oncology Group - Springdale
Springdale, Arkansas · Recruiting
Providence Medical Foundation
Fullerton, California · Recruiting
Local Institution - 0682
Loma Linda, California · Not yet recruiting
Helios Clinical Research
Long Beach, California · Recruiting
National Jewish Health Medical Center
Denver, Colorado · Recruiting
Medical Oncology Hematology Consultants, PA
Newark, Delaware · Recruiting
Morton Plant Hospital - BayCare Health System
Clearwater, Florida · Recruiting
Cancer Specialists of North Florida
Jacksonville, Florida · Recruiting
Local Institution - 0696
Miami, Florida · Not yet recruiting
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala
Ocala, Florida · Recruiting
Mid Florida Hematology and Oncology Center
Orange City, Florida · Recruiting
Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida · Recruiting
Florida Clinical Trials Group.
Plantation, Florida · Recruiting
St. Anthony's Hospital
St. Petersburg, Florida · Recruiting
Florida Clinical Trials Group.
Tamarac, Florida · Recruiting
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida · Recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
Marietta, Georgia · Recruiting
Illinois Cancer Specialists
Arlington Heights, Illinois · Recruiting
University of Illinois at Chicago
Chicago, Illinois · Recruiting
Springfield Clinic Main Campus
Springfield, Illinois · Recruiting
Northwest Cancer Centers, P.C.
Dyer, Indiana · Recruiting
Parkview Research Center at Parkview Regional Medical Center
Fort Wayne, Indiana · Recruiting
Mercy Medical Center
Cedar Rapids, Iowa · Recruiting
Saint Elizabeth Medical Center Edgewood
Edgewood, Kentucky · Recruiting
The University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky · Recruiting
Owensboro Medical Health System
Owensboro, Kentucky · Recruiting
Mercy Health-Paducah Medical Oncology and Hematology
Paducah, Kentucky · Recruiting
Louisiana State University Health Sciences Shreveport
Shreveport, Louisiana · Recruiting
Velocity Clinical Research, Annapolis
Annapolis, Maryland · Recruiting
Maryland Oncology Hematology - Columbia
Columbia, Maryland · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Karmanos Cancer Institute
Detroit, Michigan · Recruiting
SSM Health Cancer Care - Fenton
Fenton, Missouri · Recruiting
Local Institution - 0678
Cooperstown, New York · Not yet recruiting
Ellis Hospital
Schenectady, New York · Recruiting
White Plains Hospital
White Plains, New York · Recruiting
WellSpan Oncology Research
York, Pennsylvania · Recruiting
St Francis Cancer Center
Greenville, South Carolina · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
Showing 40 of 317 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.